Search for: "SANDOZ INTERNATIONAL GmbH" Results 21 - 40 of 47
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Dec 2015, 12:56 pm
" is the bold question posited by the Centre for International Governance Innovation (CIGI), the Blackberry-founded research centre in Waterloo, Canada. [read post]
25 Feb 2011, 8:02 am by Steve Hall
The packaging indicated the drug was made by Sandoz International GmbH, a European generics company, Kentucky Justice and Public Safety Cabinet spokeswoman Jennifer Brislin said. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat)… [read post]
23 Sep 2022, 9:39 am by Annsley Merelle Ward
However, the international search report confirmed the lack of novelty of the invention, even in that amended form. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation: Grunenthal GmbH v. [read post]
23 Feb 2015, 2:55 am
.* The Richemont ruling and beyond: dealing with counterfeit websites and the intermediaries that host themKatfriend Tim Behean provides another insightful analysis of Cartier International AG and Others v British Sky Broadcasting Ltd and Others [2014] EWHC 3354 (Ch) [following Eleonora's Katpost here], explaining what Arnold J's decision has achieved, how they go about dealing with blocking injunctions in the United States -- and where we might go from here.*… [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
3 Feb 2011, 8:39 am by Steve Hall
The shipments of thiopental entering the U.S. originated from an Austrian facility owned by Sandoz International GmbH, a German company, according to the complaint. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
28 Mar 2012, 8:30 am by Steve Hall
According to court filings, the shipments of thiopental entering the United States came from an Austrian facility owned by Sandoz International GmbH. [read post]
5 Oct 2020, 2:00 am by Annsley Merelle Ward
Standard Verlags GmbH, the Judge started by recalling that the "close connection" criteria requires the same situation of fact and law. [read post]